DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

2026-11-10 · BOTH · TopGLP1Providers Data Desk

GLP-1 Telehealth Pricing Models, Counted (2026)

Of the 40 GLP-1 telehealth programs in TopGLP1Providers’ dataset as of November 10, 2026, 14 charge one flat all-in price with no membership, 3 add a mandatory membership or program fee, 3 tier by dose, 8 route you to brand medication through a plan or insurance service, 2 are manufacturer pharmacies and 10 publish no price we could verify.

Released · Last reviewed · how we verify

Price tables tell you what a program charges. They do not tell you how it charges, and the how decides what your bill looks like in month six. So we sorted every program in our open dataset by the way it prices compounded or brand GLP-1 medication, then put a dated price band on each group.

How we counted. Each program sits in exactly one model, set by its newest dated read: the August 5–9, 2026 seed captures for most programs; October 15, 2026 first-party reads for Eden, Found, Henry Meds, IVIM Health, LifeMD, Mochi Health and ShedRx; and November 20, 2026 for NexLife. We filed programs by their tirzepatide record, and the four that price only semaglutide by that. Where a program charges both a fee and a dose-based price, we filed it under the fee, because the fee is the part you pay every month no matter what.

All prices are all-in: medication plus any mandatory recurring membership or program fee, at the maintenance dose (tirzepatide 10 mg, semaglutide 2.4 mg), before tax and before prepaid discounts.

Six pricing models, plus the manufacturers

How the 40 programs in TopGLP1Providers’ dataset charge, by newest dated read (August 2026 captures; October 15, 2026 reads; NexLife November 20, 2026). Bands are tirzepatide all-in monthly unless noted. Counted November 10, 2026.
ModelProgramsWhoDated price band
Flat all-in, no membership14NexLife, Eden, Found, Yucca Health, SkinnyRx, Amble Health, TrimRx, Fridays, MEDVi, Remedy Meds; semaglutide only: Oak Longevity, Noom Med, Enhance.MD, bmiMD$129 (NexLife, Nov 6; Eden, Oct 15) to $399 (August captures); semaglutide-only $133 to $289 (August captures)
Medication plus mandatory membership or program fee3IVIM Health, Mochi Health, Lavender Sky HealthFrom $192 (IVIM, Oct 15) to $352 (Lavender Sky, August capture)
Dose-tiered, no membership3ShedRx, Henry Meds, Fifty 410Starting prices only: $133 (Fifty 410, August) to $239 (ShedRx, Oct 15)
Brand-channel plan (brand medication plus a fee or visit)3LifeMD, Hims & Hers, Sesame Care$348 to $448 at LifeMD’s starting doses (Oct 15); others unpublished
Insurance-navigation membership5Ro, WeightWatchers Clinic, Calibrate, Form Health, PlushCareFees of $74 to $145 a month (August captures), plus medication
No published price10Emerge, Big Easy Weight Loss, Rift, Gimme Care, Trillium, Goby Meds, OrderlyMeds, Embody, MyStart Health, Gala HealthNone we could verify
Manufacturer self-pay pharmacy2LillyDirect, NovoCareZepbound vials $299 to $449 by dose; Wegovy pens $349 (Oct 15)
Total40

The census is a sort of business models, not a ranking. Price tables elsewhere on this site sort by the dated figure; our ranking is a separate editorial score.

1. Flat all-in, no membership: 14 programs

One price covers the medication and the care, and it does not change with the dose. This is the most common model in the dataset, at 14 of 40 programs.

The band is wide. NexLife lists $129 a month month to month (read November 20, 2026) and Eden lists $129 (read October 15, 2026). The August 2026 captures run up to $399 at MEDVi and Remedy Meds. Twelve months at $129 is $1,548; twelve at $399 is $4,788. That is a $3,240 spread inside a single model. Three of the ten tirzepatide figures, Amble Health, Fridays and Remedy Meds, are third-party reports we have not confirmed on the provider’s page.

Two programs joined this group since August. Eden’s August 5 capture was $408, a $309 medication rate plus a $99 membership; its October 15 page lists $129 with “No membership fees.” Found’s October 15 page lists $359 per 28-day cycle month to month, a price it says covers clinical care, medication and membership.

More on this model: flat-rate programs and programs with no membership.

2. Medication plus a mandatory fee: 3 programs

The medication has one price and a required membership or program fee sits on top. Our all-in figures add the two.

IVIM Health prints compounded tirzepatide “starting at $117/mo + $75/mo Program Fee” (read October 15, 2026), so from $192 all-in. The fee alone is 12 × $75 = $900 a year, and a year at the starting price is 12 × $192 = $2,304. Lavender Sky Health’s August capture was $352 at the 10 mg tier, including a $25 monthly fee, or $300 a year in fees. Mochi Health’s August capture was $278 including a $79 membership; its October 15 page prints a membership of $199 for 12 months and no compounded price.

All three also price by dose. IVIM and Lavender Sky did so in August, and Mochi’s own blog post, updated September 18, 2026, describes per-dose tirzepatide pricing of $90 to $199 a month with membership billed separately. See where membership fees hide.

3. Dose-tiered, no membership: 3 programs

The price rises as your prescribed dose rises. These programs advertise the entry price, the smallest figure on the ladder.

ShedRx prints compounded tirzepatide “starting as low as $239/mo” (read October 15, 2026). Its August capture showed the ladder: $199 at entry and $289 at 10 mg. Henry Meds says its GLP-1 price “varies by treatment plan and dosing, but starts at $179/month,” including visits, medication and supplies (read October 15, 2026). Fifty 410’s August capture was a $133 starting price with no 10 mg figure.

Worked example, using ShedRx’s August ladder as an illustration, not a dosing plan. If your prescriber moved you to the 10 mg tier from month three, the year would cost 2 × $199 + 10 × $289 = $398 + $2,890 = $3,288. At the entry price all year it would be 12 × $199 = $2,388. The gap is $900. At Lavender Sky, the August gap between entry ($200) and 10 mg ($352) was $152 a month, or $1,824 over a year at maintenance. More in flat vs dose-tiered pricing.

4. Brand-channel plan: 3 programs

These programs prescribe FDA-approved brand medication, such as Zepbound or Wegovy, and charge for the plan or the visit on top.

LifeMD’s October 15, 2026 page lists the Wegovy pen from $199 and the Zepbound vial from $299 and says the price “does not include the monthly program & provider fee of $149.” That makes $348 or $448 a month at those starting doses, and the fee alone is 12 × $149 = $1,788 a year. LifeMD printed no compounded price on that read. Hims & Hers and Sesame Care published no price we could capture in August; Sesame prices visits by clinician and leaves the medication cost to your pharmacy or a manufacturer program.

5. Insurance-navigation membership: 5 programs

The membership pays for clinical visits and help getting a brand GLP-1 covered by your insurer. Medication is billed through your insurance or at the manufacturer’s self-pay rate.

In our August captures, Ro’s membership was $145 a month and WeightWatchers Clinic’s $74. Over a year that is $1,740 and $888 in fees. Calibrate quotes its program at enrollment, Form Health bills visits through insurance, and PlushCare prices visits. For scale, a year of self-pay Zepbound vials at 10 mg is 12 × $449 = $5,388, and a year of Wegovy pens at $349 is $4,188 (read October 15, 2026). The fee pays off only if coverage comes through.

6. No published price: 10 programs

Ten programs printed no price we could verify. Six had no figure at all in August. OrderlyMeds states $299 for tirzepatide, but we could not capture it on a pricing page. Embody, MyStart Health and Gala Health figures come only from other comparison sites, so we list none. If you consider one, ask for the 10 mg price in writing before you pay anything.

Plus two manufacturer pharmacies

LillyDirect sells Zepbound vials at $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5 to 15 mg when each refill comes within 45 days; otherwise 7.5 mg is $499 and 10 to 15 mg is $699. That ladder is itself dose-tiered: $150 a month between entry and maintenance. NovoCare sells Wegovy pens at $349 a month at every dose from 0.25 to 2.4 mg, Wegovy HD 7.2 mg at $399, and the Wegovy pill at $149, $199 or $299 by dose (read October 15, 2026).

Two programs change the math for some buyers. Lilly’s savings card for commercially insured patients allows up to 11 fills a calendar year, and its savings end December 31, 2026. The Medicare GLP-1 Bridge gives eligible Part D enrollees Foundayo, Wegovy or the Zepbound KwikPen, not vials, for a $50 copay through December 31, 2027. That is 12 × $50 = $600 a year. Eligibility starts at a BMI of 35, with lower thresholds for listed conditions, and people with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge, though their Part D plan might cover a GLP-1. See brand-name GLP-1s online.

What this means for you

Compounded tirzepatide and semaglutide are not FDA-approved. They are made with the drugs in Zepbound and Wegovy but are not the same products. Whatever the model, confirm the price at checkout on the day you enroll, and talk to a licensed prescriber about whether a GLP-1 suits you. How we date and verify each figure is on our methodology page.

Frequently asked

What is the most common way GLP-1 telehealth programs charge?

In TopGLP1Providers’ dataset of 40 programs, counted November 10, 2026, the most common model is a flat all-in price with no membership: 14 programs. Their tirzepatide prices run from $129 a month (NexLife, read November 20, 2026; Eden, read October 15, 2026) to $399 in August 2026 captures. Ten programs publish no price we could verify, and three add a mandatory fee.

How much does a GLP-1 membership fee add over a year?

Multiply the monthly fee by 12. IVIM Health’s $75 monthly program fee (read October 15, 2026) adds $900 a year. LifeMD’s $149 monthly program fee adds $1,788. In our August 2026 captures, Ro’s $145 membership came to $1,740 a year and WeightWatchers Clinic’s $74 to $888. Those amounts come before any medication is paid for.

Is dose-tiered GLP-1 pricing a bad deal?

Not always. A dose-tiered program can cost less in the first months, while you are on a low dose. The risk is the step up. ShedRx’s August 2026 capture ran from $199 at entry to $289 at 10 mg, so moving to 10 mg from month three makes a year $3,288 instead of $2,388. Ask for the maintenance-dose price in writing before you start.

Why do some GLP-1 programs show no price?

Ten of the 40 programs in our dataset printed no price we could verify on their own pages. Some quote at enrollment, some send prescriptions to your pharmacy, and for three we hold only figures reported by other comparison sites, which we do not publish as verified. If you consider one, ask for the full monthly price at the 10 mg tirzepatide or 2.4 mg semaglutide dose.

Where does Medicare fit among GLP-1 pricing models?

The Medicare GLP-1 Bridge sits outside the telehealth models. From July 1, 2026 to December 31, 2027, eligible Part D enrollees can get Foundayo, Wegovy or the Zepbound KwikPen, not vials, for a $50 copay, or $600 over 12 months. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge, though their Part D plan might cover a GLP-1.

Sources

  1. NexLife, “Tirzepatide: all plans” (nexlife.us/pages/tirzepatide-all-plans), read November 20, 2026.
  2. Eden Health, “GLP-1 weight loss” (www.eden.health/glp-1/weight-loss), read October 15, 2026.
  3. IVIM Health, “Weight loss” (www.ivimhealth.com/weight-loss), read October 15, 2026.
  4. Found, “Compounded tirzepatide” (joinfound.com/store/compounded-tirzepatide), read October 15, 2026.
  5. Mochi Health, “Weight loss” (joinmochi.com/weight-loss), read October 15, 2026.
  6. Mochi Health, “New Per-Dose Pricing: What Changed (updated September 18, 2026)” (joinmochi.com/blog/per-dose-pricing-mochi-health), read October 15, 2026.
  7. ShedRx, “Home page pricing” (www.tryshed.com), read October 15, 2026.
  8. Henry Meds, “GLP-1 weight management” (henrymeds.com/treatments/weight-management/glp-1-weight-management), read October 15, 2026.
  9. LifeMD, “Weight management” (lifemd.com/weight-management), read October 15, 2026.
  10. Eli Lilly, “Zepbound coverage and savings” (zepbound.lilly.com/coverage-savings), read October 15, 2026.
  11. Novo Nordisk, “NovoCare: Wegovy” (www.novocare.com/patient/medicines/wegovy.html), read October 15, 2026.
  12. CMS, “Medicare GLP-1 Bridge” (www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge), read October 15, 2026.
  13. U.S. FDA, “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of October 1, 2026)” (www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss), read October 15, 2026.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Winning GLP-1 coverage: the 2026 playbookPrepaid GLP-1 plans: what the discount buysWhat a year of tirzepatide actually costsThe brand price collapse, datedCompounded tirzepatide vs Zepbound